7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Pneumaticos SG et al. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. 2013 Expert Opin. Ther. Targets pmid:24024908
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Kitamura K et al. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. 2013 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:23632157
Zhong Z et al. Comparison of the biological response of osteoblasts after tension and compression. 2013 Eur J Orthod pmid:21402736
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Tisato V et al. GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 2013 Mediators Inflamm. pmid:24327798
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Revu S et al. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. 2013 Arthritis Res. Ther. pmid:24295447
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Mogelvang R et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. 2012 Am. J. Cardiol. pmid:22100028
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Chung E and Rylander MN Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. 2012 Cell Stress Chaperones pmid:22116637
Udomsuk L et al. Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. 2012 Fitoterapia pmid:23041523
Li J et al. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. 2012 J Biomech pmid:22119108
Xiang G et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. 2012 Exp. Clin. Endocrinol. Diabetes pmid:23070830
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Tanaka M et al. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. 2012 Bone Marrow Transplant. pmid:22120987
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Blázquez-Medela AM et al. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. 2012 Eur. J. Clin. Invest. pmid:22050177
Chaves MD et al. Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. 2012 J Craniomaxillofac Surg pmid:22513050
Xu S et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. 2012 Rheumatol. Int. pmid:22057136
Koole D et al. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22516062
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Rattazzi M et al. Osteoprotegerin levels are increased in patients with venous thromboembolic disease. 2012 J. Thromb. Haemost. pmid:22486966
Ozkok A et al. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. 2012 Clin J Am Soc Nephrol pmid:22490874
Duarte PM et al. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. 2012 J. Periodontol. pmid:21859322
Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. 2012 Nephrol. Dial. Transplant. pmid:21750158
Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. 2012 Int. J. Cardiol. pmid:22592030
Güncü GN et al. Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. 2012 Cytokine pmid:22592038
Helo S et al. Role of denosumab in prostate cancer. 2012 Prostate Cancer Prostatic Dis. pmid:22370723
Røysland R et al. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. 2012 Heart pmid:22373720
Brambila-Tapia AJ et al. MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. 2012 Dis. Markers pmid:22377704
Renno AC et al. Ultrasound therapy modulates osteocalcin expression during bone repair in rats. 2012 Ultrasonics pmid:21820693
Bergström I et al. Physical training increases osteoprotegerin in postmenopausal women. 2012 J. Bone Miner. Metab. pmid:21823052
Nanda KS et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. 2012 Cytokine pmid:22863720
Dickerson TJ et al. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. 2012 J. Autoimmun. pmid:22867712
Chao TH et al. Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. 2012 J Chin Med Assoc pmid:22824048
Wang Y et al. Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. 2012 Connect. Tissue Res. pmid:22827452
Zhou WJ et al. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:22883830
Taddei SR et al. Role of CCR2 in orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22284282
Campia U et al. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. 2012 Heart pmid:22543836
Choe WS et al. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. 2012 J. Genet. pmid:22546829
Bloch SL et al. The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. 2012 Anat Rec (Hoboken) pmid:22577084
Tsubaki M et al. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. 2012 Mol. Cell. Endocrinol. pmid:22579611
Wang YD et al. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. 2012 Chin. Med. J. pmid:22613593
Ma Y et al. Effects of brucine on bone metabolism in multiple myeloma. 2012 Mol Med Rep pmid:22614932
Ma D et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. 2012 J. Proteome Res. pmid:22616666
Canon J et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. 2012 Breast Cancer Res. Treat. pmid:22926264
Shuid AN et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. 2012 BMC Complement Altern Med pmid:22967165
Fichna M et al. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. 2012 J. Physiol. Pharmacol. pmid:23388484
Sanchez C et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. 2012 Arthritis Rheum. pmid:22034083
Torchinsky A et al. Bone loss in adult offspring induced by low-dose exposure to teratogens. 2012 J. Bone Miner. Metab. pmid:21960178
Fitzgerald O and Chandran V Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012 J. Rheumatol. pmid:22298273
Silva JA et al. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. 2012 Cells Tissues Organs (Print) pmid:22301390
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Kennedy OD et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. 2012 Bone pmid:22342796
Leistner DM et al. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. 2012 Circ Heart Fail pmid:22936827
Liu T et al. [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230665
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Mlakar SJ et al. Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. 2012 Maturitas pmid:22221655
Kadkhodazadeh M et al. Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. 2012 Eur J Oral Implantol pmid:23304691
Curl L et al. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. 2012 Aust Orthod J pmid:23304971
Emanuele E et al. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. 2012 Front Biosci (Elite Ed) pmid:22201906
Karatolios K et al. Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. 2012 Clin. Biochem. pmid:22202560
Delgado-Calle J et al. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. 2012 Epigenetics pmid:22207352
Bao L et al. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. 2012 Joint Bone Spine pmid:22154615
Shahnazari M et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. 2012 Bone pmid:22154841
Çanga A et al. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. 2012 J Cardiol pmid:22727437
Yoon WJ et al. Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. 2012 Food Chem. Toxicol. pmid:22727857
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Khoury N et al. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. 2012 J. Clin. Endocrinol. Metab. pmid:22730513
Oue E et al. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. 2012 Biochem. Biophys. Res. Commun. pmid:22771802
Cui L et al. Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:22776650
Zhang M et al. [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934488
Liu L et al. [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22594224
Zhou W et al. [Expression of receptor activator nuclear factor kappa B ligand and osteoprotegerin in peri-implant soft tissue and bone tissue]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22389960

Table of Content